Investigation on the modified continual reassessment method in phase I clinical trial
![]() |
강승호 (이화여자대학교 통계학과) |
1 |
Methods for dose finding studies in cancer trials: A review and results of a Monte Carlo study
/
DOI ScienceOn |
2 |
여러 약제의 상승효과 검정을 위한 통계적 기법
/
과학기술학회마을 |
3 |
임상실험에서 그룹축차방법들의 비교
/
과학기술학회마을 |
4 |
Phase I and Pharmacokinetic study of irofulven, a novel mushroomderived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies
/
DOI |
5 |
An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses
/
DOI ScienceOn |
6 |
An evaluation of Phase I cancer clinical trial designs
/
DOI ScienceOn |
7 |
층화된 임상시험에서 생존분포의 비교를 위한 표본수의 결정
/
과학기술학회마을 |
8 |
두 개의 제제형식과 기존제제간의 생물학적 동등성 검정
/
과학기술학회마을 |
9 |
Estimation of Maximal Tolerated Dose in Sequential Phase I Clinical Trials
/
과학기술학회마을 |
10 |
Phase I does finding study of a new taxane, RPR 10988A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors
/
DOI |
11 |
임상시험에서 치료율 비교를 위한 집단축차검정법에 관한 고찰
/
과학기술학회마을 |
12 |
Practical modifications of the continual reassessment method for phase I cancer clinical trials
/
DOI ScienceOn |
13 |
생존함수의 비교연구를 위한 표본수의 결정
/
과학기술학회마을 |
14 |
A phase I evaluation of multitargeted antifolate(MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment for dose escalation
/
DOI ScienceOn |
15 |
Continual reassessment method: A practical design for phase I clinical trials in cancer
/
DOI ScienceOn |
16 |
Some practical improvements in the continual reassessment method for phase I studies
/
DOI ScienceOn |
17 |
Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth
/
DOI ScienceOn |
18 |
The expected toxicity rate at the maximum tolerated dose in the standard phase I cancer clinical trial design
/
DOI ScienceOn |
19 |
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants
/
DOI ScienceOn |
![]() |